AGT and Myocardial fibrosis: Further mechanistic screening revealed that both interventions (hepatic AGT knockout vs systemic AngII inhibition) showed similar outcomes in terms of cardiac inflammation, myocardial fibrosis, and ventricular hypertrophy.